|ECR 2018 / C-1501|
|Advanced renal cell carcinoma and the new targeted anticancer therapies: When the progression is not progression|
- Know the actual treatment and new therapies in mRCC.
- Recognize the molecular basis behind novel anticancer agents in mRCC and how affects radiological response.
- Describe typical and atypical radiologic response with the use of TAT in mRCC
Thematically related posters
ECR 2018 / C-1742
CT of hepatocellular carcinoma in non-alcoholic fatty liver disease: imaging characteristics and inter-rater agreement
ECR 2018 / C-1983
The role of cross-sectional imaging features for characterisation of incidental splenic lesions